| Bioactivity | Pyridoxylamine dihydrochloride is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhibitor, to protect against diabetes-induced retinal vascular lesions[1]. |
| Invitro | Pyridoxylamine (PM), a member of the B6 vitamer family, is a potent scavenger of reactive carbonyls, inhibiting the late stages of glycation reactions that lead to AGE formation[1]. |
| Name | Pyridoxylamine dihydrochloride |
| CAS | 524-36-7 |
| Formula | C8H14Cl2N2O2 |
| Molar Mass | 241.11 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
Pyridoxylamine dihydrochloride
CAS: 524-36-7 F: C8H14Cl2N2O2 W: 241.11
Pyridoxylamine dihydrochloride is an advanced glycation end production (AGEs) and lipoxidation end products (ALEs) inhib
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.